On the subject of ViiV's manufacturing CRL in December - that is potentially huge for Leronlimab in that now CYDY has a chance to be the first HIV injection approved by FDA. Even though Leronlimab is presumably a better product than ViiV's product, it is still a huge advantage to be the first HIV injection on the market. I am not sure how long it will take for ViiV to re-file with FDA or how long it will take for FDA to review, but if NP files BLA in the next few weeks then CYDY can get 6 month FDA approval which would hopefully be before ViiV's potential approval!